ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares Press release LEIDEN, The Netherlands and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 16, 2019
ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer Press release Proven leader with deep worldwide ophthalmology experience, including multiple approvals globally October 05, 2020
ProQR to Present at Scientific and Investor Conferences in September Press release LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 06, 2016
ProQR to Present at Upcoming JMP Securities Life Sciences Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 10, 2021
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. December 22, 2022
ProQR to Present at Upcoming Scientific Meeting and Investor Conference Press release LEIDEN, the Netherlands, Feb. 06, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 06, 2018
ProQR Announces Financial Results for the Third Quarter of 2018 Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 07, 2018
ProQR Therapeutics Announces Results for the Third Quarter of 2014 Press release LEIDEN, the Netherlands, Nov. 24, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 24, 2014
ProQR to Present at the Chardan Inaugural Gene Therapy Conference Press release LEIDEN, the Netherlands, Oct. 06, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 06, 2017
ProQR Announces Financial Results for the Second Quarter of 2018 Press release LEIDEN, The Netherlands, Aug. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. August 08, 2018
